BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34156701)

  • 1. Yes-associated protein regulates the hepatoprotective effect of vitamin D receptor activation through promoting adaptive bile duct remodeling in cholestatic mice.
    Xie J; Fan Y; Jia R; Yang F; Ma L; Li L
    J Pathol; 2021 Sep; 255(1):95-106. PubMed ID: 34156701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paricalcitol inhibits oxidative stress-induced cell senescence of the bile duct epithelium dependent on modulating Sirt1 pathway in cholestatic mice.
    Jia R; Yang F; Yan P; Ma L; Yang L; Li L
    Free Radic Biol Med; 2021 Jun; 169():158-168. PubMed ID: 33872698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yes-associated protein regulates the hepatic response after bile duct ligation.
    Bai H; Zhang N; Xu Y; Chen Q; Khan M; Potter JJ; Nayar SK; Cornish T; Alpini G; Bronk S; Pan D; Anders RA
    Hepatology; 2012 Sep; 56(3):1097-107. PubMed ID: 22886419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D nuclear receptor deficiency promotes cholestatic liver injury by disruption of biliary epithelial cell junctions in mice.
    Firrincieli D; Zúñiga S; Rey C; Wendum D; Lasnier E; Rainteau D; Braescu T; Falguières T; Boissan M; Cadoret A; Housset C; Chignard N
    Hepatology; 2013 Oct; 58(4):1401-12. PubMed ID: 23696511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.
    Wang Y; Aoki H; Yang J; Peng K; Liu R; Li X; Qiang X; Sun L; Gurley EC; Lai G; Zhang L; Liang G; Nagahashi M; Takabe K; Pandak WM; Hylemon PB; Zhou H
    Hepatology; 2017 Jun; 65(6):2005-2018. PubMed ID: 28120434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D Receptor Activation Targets ROS-Mediated Crosstalk Between Autophagy and Apoptosis in Hepatocytes in Cholestasic Mice.
    Zheng Z; Xie J; Ma L; Hao Z; Zhang W; Li L
    Cell Mol Gastroenterol Hepatol; 2023; 15(4):887-901. PubMed ID: 36280140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGC1α deficiency reverses cholestasis-induced liver injury via attenuating hepatic inflammation and promoting bile duct remodeling.
    Li D; Ye C; Liu P; Sun T; Qin Y; Wan X
    Acta Histochem; 2023 Dec; 125(8):152097. PubMed ID: 37813066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
    Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
    Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic rats.
    McMillin M; DeMorrow S; Glaser S; Venter J; Kyritsi K; Zhou T; Grant S; Giang T; Greene JF; Wu N; Jefferson B; Meng F; Alpini G
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G410-G418. PubMed ID: 28751425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D3 abates BDL-induced cholestasis and fibrosis in rats via regulating Hedgehog pathway.
    Abdel-Rahman N; Sharawy MH; Megahed N; El-Awady MS
    Toxicol Appl Pharmacol; 2019 Oct; 380():114697. PubMed ID: 31394158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
    Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J
    Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation.
    Lu ZN; Niu WX; Zhang N; Ge MX; Bao YY; Ren Y; Guo XL; He HW
    Acta Pharmacol Sin; 2021 Nov; 42(11):1808-1820. PubMed ID: 34465912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
    Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
    Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of necroptosis in human and experimental cholestasis.
    Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
    Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Notch signaling pathway participates in the differentiation of hepatic progenitor cells into bile duct epithelial cells and progression of hepatic fibrosis in cholestatic liver fibrosis rat].
    Mu YP; Zhang X; Xu Y; Fan WW; Li XW; Chen JM; Chen GF; Liu P
    Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):400-405. PubMed ID: 28591987
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitamin D Receptor Activation Reduces Hepatic Inflammation via Enhancing Macrophage Autophagy in Cholestatic Mice.
    Wen T; Xie J; Ma L; Hao Z; Zhang W; Wu T; Li L
    Am J Pathol; 2024 Mar; 194(3):369-383. PubMed ID: 38104651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
    Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
    Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
    Wang H; Vohra BP; Zhang Y; Heuckeroth RO
    Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C/EBP homologous protein-induced loss of intestinal epithelial stemness contributes to bile duct ligation-induced cholestatic liver injury in mice.
    Liu R; Li X; Huang Z; Zhao D; Ganesh BS; Lai G; Pandak WM; Hylemon PB; Bajaj JS; Sanyal AJ; Zhou H
    Hepatology; 2018 Apr; 67(4):1441-1457. PubMed ID: 28926118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-200c-3p targets SESN1 and represses the IL-6/AKT loop to prevent cholangiocyte activation and cholestatic liver fibrosis.
    Song Y; Tran M; Wang L; Shin DJ; Wu J
    Lab Invest; 2022 May; 102(5):485-493. PubMed ID: 34880414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.